Augmedix to Announce Second Quarter 2024 Financial Results on August 12, 2024
Augmedix (Nasdaq: AUGX), a leading provider of ambient AI medical documentation and data solutions, has announced that it will release its second quarter 2024 financial results after the market closes on Monday, August 12, 2024. The company also disclosed that on July 19, 2024, it entered into a definitive agreement to be acquired by Commure, Inc., a prominent technology provider for healthcare systems. As a result of this pending acquisition, Augmedix management will not be hosting a quarterly conference call to discuss the financial results.
Augmedix (Nasdaq: AUGX), un fornitore leader di soluzioni di documentazione medica e dati basati su intelligenza artificiale ambientale, ha annunciato che rilascerà i propri risultati finanziari del secondo trimestre 2024 dopo la chiusura del mercato il lunedì 12 agosto 2024. L'azienda ha anche comunicato che il 19 luglio 2024 ha firmato un accordo definitivo per essere acquisita da Commure, Inc., un'importante azienda tecnologica per i sistemi sanitari. A causa di questa acquisizione in attesa, la direzione di Augmedix non terrà una conferenza telefonica trimestrale per discutere i risultati finanziari.
Augmedix (Nasdaq: AUGX), un proveedor líder de soluciones de documentación médica y datos basados en inteligencia artificial ambiental, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 después del cierre del mercado el lunes 12 de agosto de 2024. La compañía también reveló que el 19 de julio de 2024 firmó un acuerdo definitivo para ser adquirida por Commure, Inc., un destacado proveedor de tecnología para sistemas de salud. Como resultado de esta adquisición pendiente, la dirección de Augmedix no llevará a cabo una llamada de conferencia trimestral para discutir los resultados financieros.
Augmedix (Nasdaq: AUGX), 환경 AI 의료 문서화 및 데이터 솔루션의 선도적인 제공업체,는 2024년 2분기 재무 결과를 2024년 8월 12일 월요일 시장 폐장 후 발표할 것이라고 발표했습니다. 이 회사는 또한 2024년 7월 19일에 의료 시스템을 위한 주요 기술 제공업체인 Commure, Inc.에 인수되기 위한 최종 계약에 서명했다고 밝혔습니다. 이 인수로 인해 Augmedix 경영진은 재무 결과를 논의하기 위한 분기별 전화 회의를 개최하지 않을 것이라고 합니다.
Augmedix (Nasdaq: AUGX), un fournisseur leader de solutions de documentation médicale et de données basées sur l'IA ambiante, a annoncé qu'il publierait ses résultats financiers du deuxième trimestre 2024 après la clôture du marché le lundi 12 août 2024. L'entreprise a également révélé que le 19 juillet 2024, elle a conclu un accord définitif pour être acquise par Commure, Inc., un fournisseur de technologies important pour les systèmes de santé. En raison de cette acquisition imminente, la direction d'Augmedix ne tiendra pas de conférence téléphonique trimestrielle pour discuter des résultats financiers.
Augmedix (Nasdaq: AUGX), ein führender Anbieter von Ambient-AI-Lösungen für medizinische Dokumentation und Daten, hat angekündigt, dass die Finanzergebnisse für das zweite Quartal 2024 nach Marktschluss am Montag, den 12. August 2024 veröffentlicht werden. Das Unternehmen gab auch bekannt, dass es am 19. Juli 2024 eine endgültige Vereinbarung mit Commure, Inc. zur Übernahme getroffen hat, einem bedeutenden Technologieanbieter für Gesundheitssysteme. Infolge dieser bevorstehenden Übernahme wird das Management von Augmedix keine vierteljährliche Telefonkonferenz zur Diskussion der Finanzergebnisse abhalten.
- Augmedix has entered into a definitive agreement to be acquired by Commure, Inc., potentially strengthening its market position
- The company is maintaining transparency by releasing its Q2 2024 financial results as scheduled
- Management will not host a quarterly conference call, potentially limiting investor engagement and detailed financial discussions
SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today it anticipates releasing second quarter 2024 results after the market closes on Monday, August 12, 2024.
On July 19, 2024, Augmedix announced that it entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems. Due to this pending acquisition, management is not hosting a quarterly conference call.
About Augmedix
Augmedix (Nasdaq: AUGX) empowers clinicians to connect with patients by liberating them from administrative burden through the power of ambient AI, data, and trust. The platform transforms natural conversations into organized medical notes, structured data, and point-of-care notifications that enhance efficiency and clinical decision support. Incorporating data from millions of interactions across all care settings, Augmedix collaborates with hospitals and health systems to improve clinical, operational, and financial outcomes. Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit www.augmedix.com.
Contact Information
Investors:
Matt Chesler, CFA
FNK IR
(646) 809-2183
augx@fnkir.com
investors@augmedix.com
Media:
Kaila Grafeman
Augmedix
pr@augmedix.com
FAQ
When will Augmedix (AUGX) release its Q2 2024 financial results?
Why isn't Augmedix (AUGX) hosting a quarterly conference call for Q2 2024 results?
What major corporate event did Augmedix (AUGX) announce on July 19, 2024?
